標(biāo)題: Titlebook: Gene Therapy of Cancer; Methods and Protocol Wolfgang Walther Book 2022Latest edition The Editor(s) (if applicable) and The Author(s), unde [打印本頁(yè)] 作者: 果園 時(shí)間: 2025-3-21 17:45
書(shū)目名稱Gene Therapy of Cancer影響因子(影響力)
書(shū)目名稱Gene Therapy of Cancer影響因子(影響力)學(xué)科排名
書(shū)目名稱Gene Therapy of Cancer網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Gene Therapy of Cancer網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Gene Therapy of Cancer被引頻次
書(shū)目名稱Gene Therapy of Cancer被引頻次學(xué)科排名
書(shū)目名稱Gene Therapy of Cancer年度引用
書(shū)目名稱Gene Therapy of Cancer年度引用學(xué)科排名
書(shū)目名稱Gene Therapy of Cancer讀者反饋
書(shū)目名稱Gene Therapy of Cancer讀者反饋學(xué)科排名
作者: HATCH 時(shí)間: 2025-3-21 23:46 作者: CHECK 時(shí)間: 2025-3-22 03:48 作者: ALIEN 時(shí)間: 2025-3-22 07:34 作者: Amorous 時(shí)間: 2025-3-22 10:09 作者: Canary 時(shí)間: 2025-3-22 13:31
TCR Gene Therapy for Cancertwo paths of generating antigen-specific T cells, first, T cell stimulation with autologous dendritic cells pulsed with antigen peptide, second, in vivo T cell stimulation with peptide or DNA by gene gun application in a suitable mouse model followed by in vitro enrichment of peptide-reactive T cell作者: Canary 時(shí)間: 2025-3-22 20:54
Gene Gun Her2/neu DNA Vaccination: Evaluation of Vaccine Efficacy in a Syngeneic Her2/neu Mouse TumoNA vaccines, particularly in large animals and humans, different strategies have been pursued. These vaccination strategies are based on different application routes, schedules and coexpression of immunomodulatory molecules as adjuvants. Our mouse tumor model offers the possibility to investigate He作者: indenture 時(shí)間: 2025-3-22 21:53
Construction of Minicircle Suicide Genes Coding for Ribosome-Inactivating Proteinsill themselves by expressing toxic ribosome-inactivating proteins. Plasmids are stable and easy-to-produce vectors, but they have some disadvantages due to the bacterial backbone. Applying the minicircle technology, this problem can be solved with manageable effort in a well-equipped laboratory. Wit作者: 遭受 時(shí)間: 2025-3-23 04:12 作者: 杠桿 時(shí)間: 2025-3-23 09:13 作者: 閹割 時(shí)間: 2025-3-23 13:06 作者: 浸軟 時(shí)間: 2025-3-23 16:58 作者: syring 時(shí)間: 2025-3-23 19:21
A qPCR-Based Method for Quantification of Replication Competent Adenovirus (RCA) in Conditionally Reoncerns in clinical usage. Cell-based assays can detect RCA in batches of nonreplicating adenoviral vectors but cannot distinguish RCA from conditionally replicating oncolytic adenoviruses. Considering the great potential in using oncolytic viruses for cancer treatment, there is a need for comprehen作者: 愛(ài)哭 時(shí)間: 2025-3-23 22:59 作者: 天空 時(shí)間: 2025-3-24 02:48
Visualized Cancer Immunotherapy with Engineered like receptor 5 (TLR5) that can activate robust host immune system, is an excellent adjuvant for cancer immunotherapy with high binding affinity to TLR5. Here, we constructed attenuated . that expresses flagellin B (FlaB) with a controlled expression system to enhance targeted cancer immunotherapy w作者: gentle 時(shí)間: 2025-3-24 08:00
https://doi.org/10.1007/978-1-0716-2441-8CAR-T cells; Suicide gene therapy; Gene replacement; Gene suppression; Oncolytic therapy作者: gerontocracy 時(shí)間: 2025-3-24 11:45
978-1-0716-2443-2The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Busines作者: 使饑餓 時(shí)間: 2025-3-24 18:07 作者: Abrade 時(shí)間: 2025-3-24 21:31 作者: Facilities 時(shí)間: 2025-3-25 00:37
Sahat M. Pasaribu,Abduh Sudiyantoh the initial intent to repair or replace defective genes. Gene therapy has been adapted for treatment of malignant diseases to improve the outcome of cancer patients. In fact, cancer gene therapy has rapidly gained great interest and evolved into a research field with highest proportion of research作者: AXIS 時(shí)間: 2025-3-25 06:30 作者: 豪華 時(shí)間: 2025-3-25 10:23 作者: Callus 時(shí)間: 2025-3-25 14:56 作者: Fraudulent 時(shí)間: 2025-3-25 17:48
f receptor properties for adoptive T-cell therapies. Multiple streams of technological platforms have been developed in the recent decades to genetically modify primary T cells including nonviral platforms such as transposon-based systems (PiggyBac, Sleeping Beauty), TALENs, or CRISPR-Cas9). The pro作者: Obverse 時(shí)間: 2025-3-25 22:38
https://doi.org/10.1007/978-94-017-1053-4two paths of generating antigen-specific T cells, first, T cell stimulation with autologous dendritic cells pulsed with antigen peptide, second, in vivo T cell stimulation with peptide or DNA by gene gun application in a suitable mouse model followed by in vitro enrichment of peptide-reactive T cell作者: abracadabra 時(shí)間: 2025-3-26 02:28
https://doi.org/10.1007/978-3-030-50468-7NA vaccines, particularly in large animals and humans, different strategies have been pursued. These vaccination strategies are based on different application routes, schedules and coexpression of immunomodulatory molecules as adjuvants. Our mouse tumor model offers the possibility to investigate He作者: CAB 時(shí)間: 2025-3-26 05:37
Greenhouse Gases: A Historical Perspective,ill themselves by expressing toxic ribosome-inactivating proteins. Plasmids are stable and easy-to-produce vectors, but they have some disadvantages due to the bacterial backbone. Applying the minicircle technology, this problem can be solved with manageable effort in a well-equipped laboratory. Wit作者: FRET 時(shí)間: 2025-3-26 09:54
https://doi.org/10.1007/978-94-017-7462-8rse modes of action, the . enterotoxin (CPE) is in focus to treat solid cancers. This toxin targets the tight junction proteins claudin-3 and -4 (Cldn-3/4), which are frequently overexpressed in solid cancers. Binding to these claudins induces pore formation in the host cell plasma membrane leading 作者: Coronary-Spasm 時(shí)間: 2025-3-26 16:43
Climate Change and AgrometeorologyNAs), and guide RNAs (gRNAs), represent a novel class of modalities that not only increase the molecular diversity of medications but also expand the range of druggable targets. To develop noncoding RNA therapeutics for the treatment of cancer diseases, we have established a novel robust RNA bioengi作者: tympanometry 時(shí)間: 2025-3-26 18:59 作者: 真 時(shí)間: 2025-3-26 21:41
Climate Change and Arctic Securityenables localized transgene expression based on engineered vectors but also triggers immunogenic tumor cell death and elicits inflammation in the tumor microenvironment. Modified oncolytic viruses encoding immunomodulators have been developed to enhance antitumor immune effects and therapeutic effic作者: 使閉塞 時(shí)間: 2025-3-27 04:18
R. Balasubramanian,V. Saravanakumaroncerns in clinical usage. Cell-based assays can detect RCA in batches of nonreplicating adenoviral vectors but cannot distinguish RCA from conditionally replicating oncolytic adenoviruses. Considering the great potential in using oncolytic viruses for cancer treatment, there is a need for comprehen作者: Fierce 時(shí)間: 2025-3-27 08:48 作者: 不連貫 時(shí)間: 2025-3-27 10:32 作者: 燦爛 時(shí)間: 2025-3-27 17:30
Sahat M. Pasaribu,Abduh Sudiyantorventions, use of novel gene therapeutic technologies such as CRISPR/Cas, sleeping beauty vectors, and development of effective cancer immunogene therapies. In this chapter, a brief overview of current key developments in cancer gene therapy is provided to gain insights into the recent directions in作者: Gossamer 時(shí)間: 2025-3-27 18:50
https://doi.org/10.1007/978-3-319-92881-4ility requirement for a globally available therapy..One alternative method for engineering of T cells is the nonviral gene transfer by . (SB) transposition. Electroporation with two nucleic acids is sufficient to achieve stable CAR transfer into T cells. One of these vectors has to encode the gene o作者: 巧思 時(shí)間: 2025-3-28 00:56
https://doi.org/10.1007/978-94-007-5757-8scribe assays that address transgene expression, biological potency and genomic vector copy numbers in polyclonal cell populations. Because transposons allow virus-free gene transfer with naked nucleic acids, the protocol can be adopted by any laboratory equipped with biological safety level S1 faci作者: Ovulation 時(shí)間: 2025-3-28 02:24 作者: Commonplace 時(shí)間: 2025-3-28 10:11
A Brief Introduction to Current Cancer Gene Therapy,rventions, use of novel gene therapeutic technologies such as CRISPR/Cas, sleeping beauty vectors, and development of effective cancer immunogene therapies. In this chapter, a brief overview of current key developments in cancer gene therapy is provided to gain insights into the recent directions in作者: 新鮮 時(shí)間: 2025-3-28 11:41 作者: painkillers 時(shí)間: 2025-3-28 18:34 作者: BILL 時(shí)間: 2025-3-28 21:31 作者: maladorit 時(shí)間: 2025-3-29 00:24
https://doi.org/10.1007/978-3-030-50468-7city of predicted peptides for Her2/neu specific memory T cells were screened and confirmed after intramuscular and intradermal application. Protection from tumor growth in tumor challenge experiments and both T cell and humoral immune responses against Her2/neu peptides are used as surrogate parameters for vaccine efficacy.作者: dysphagia 時(shí)間: 2025-3-29 05:26
R. Balasubramanian,V. Saravanakumart RCA particles in batches of conditionally replicating oncolytic adenoviruses. The assay is quantifying RCA by detection of the specific DNA sequence generated after a recombination event. Results showed that the method can successfully detect low levels of RCA, with a low limit of detection of ten viral particles.作者: nullify 時(shí)間: 2025-3-29 08:57
TCR Gene Therapy for Cancer a 5′ rapid amplification of cDNA ends (RACE)-PCR specific for TCR for TCR chain identification. After retroviral cloning, it is re-expressed on human T cells to test its applicability in adoptive T cell therapy.作者: 脾氣暴躁的人 時(shí)間: 2025-3-29 15:28
Gene Gun Her2/neu DNA Vaccination: Evaluation of Vaccine Efficacy in a Syngeneic Her2/neu Mouse Tumocity of predicted peptides for Her2/neu specific memory T cells were screened and confirmed after intramuscular and intradermal application. Protection from tumor growth in tumor challenge experiments and both T cell and humoral immune responses against Her2/neu peptides are used as surrogate parameters for vaccine efficacy.作者: 吞下 時(shí)間: 2025-3-29 19:24
A qPCR-Based Method for Quantification of Replication Competent Adenovirus (RCA) in Conditionally Ret RCA particles in batches of conditionally replicating oncolytic adenoviruses. The assay is quantifying RCA by detection of the specific DNA sequence generated after a recombination event. Results showed that the method can successfully detect low levels of RCA, with a low limit of detection of ten viral particles.作者: 感情脆弱 時(shí)間: 2025-3-29 20:35 作者: Respond 時(shí)間: 2025-3-30 00:25 作者: pulmonary-edema 時(shí)間: 2025-3-30 07:13 作者: tattle 時(shí)間: 2025-3-30 11:14 作者: 低能兒 時(shí)間: 2025-3-30 12:21
Generation of Redirected Engineered Human Chimeric Antigen Receptor (CAR) T Cellscturing steps. Here, we describe the generation of redirected engineered human CAR T cells for preclinical studies starting with the CAR design, retroviral gene transfer, detection of CAR expression, and expansion of transduced T cells.作者: 殺蟲(chóng)劑 時(shí)間: 2025-3-30 20:32 作者: 文藝 時(shí)間: 2025-3-30 23:34 作者: 語(yǔ)言學(xué) 時(shí)間: 2025-3-31 01:35
Book 2022Latest editiong and known pitfalls, and step-by-step, readily reproducible protocols...?..Authoritative and cutting-edge,?.Gene Therapy of Cancer: Methods and Protocols, Third Edition .aims to be a?useful and practical guide to new researchers and experts looking to expand their knowledge. .
